Multicentre propensity score-matched study of laparoscopic versus open repeat liver resection for colorectal liver metastases.


Journal

The British journal of surgery
ISSN: 1365-2168
Titre abrégé: Br J Surg
Pays: England
ID NLM: 0372553

Informations de publication

Date de publication:
05 2019
Historique:
received: 08 08 2018
revised: 11 10 2018
accepted: 27 11 2018
pubmed: 2 2 2019
medline: 23 10 2019
entrez: 2 2 2019
Statut: ppublish

Résumé

Repeat liver resection is often the best treatment option for patients with recurrent colorectal liver metastases (CRLM). Repeat resections can be complex, however, owing to adhesions and altered liver anatomy. It remains uncertain whether the advantages of a laparoscopic approach are upheld in this setting. The aim of this retrospective, propensity score-matched study was to compare the short-term outcome of laparoscopic (LRLR) and open (ORLR) repeat liver resection. A multicentre retrospective propensity score-matched study was performed including all patients who underwent LRLRs and ORLRs for CRLM performed in nine high-volume centres from seven European countries between 2000 and 2016. Patients were matched based on propensity scores in a 1 : 1 ratio. Propensity scores were calculated based on 12 preoperative variables, including the approach to, and extent of, the previous liver resection. Operative outcomes were compared using paired tests. Overall, 425 repeat liver resections were included. Of 271 LRLRs, 105 were matched with an ORLR. Baseline characteristics were comparable after matching. LRLR was associated with a shorter duration of operation (median 200 (i.q.r. 123-273) versus 256 (199-320) min; P < 0·001), less intraoperative blood loss (200 (50-450) versus 300 (100-600) ml; P = 0·077) and a shorter postoperative hospital stay (5 (3-8) versus 6 (5-8) days; P = 0·028). Postoperative morbidity and mortality rates were similar after LRLR and ORLR. LRLR for CRLM is feasible in selected patients and may offer advantages over an open approach.

Sections du résumé

BACKGROUND
Repeat liver resection is often the best treatment option for patients with recurrent colorectal liver metastases (CRLM). Repeat resections can be complex, however, owing to adhesions and altered liver anatomy. It remains uncertain whether the advantages of a laparoscopic approach are upheld in this setting. The aim of this retrospective, propensity score-matched study was to compare the short-term outcome of laparoscopic (LRLR) and open (ORLR) repeat liver resection.
METHODS
A multicentre retrospective propensity score-matched study was performed including all patients who underwent LRLRs and ORLRs for CRLM performed in nine high-volume centres from seven European countries between 2000 and 2016. Patients were matched based on propensity scores in a 1 : 1 ratio. Propensity scores were calculated based on 12 preoperative variables, including the approach to, and extent of, the previous liver resection. Operative outcomes were compared using paired tests.
RESULTS
Overall, 425 repeat liver resections were included. Of 271 LRLRs, 105 were matched with an ORLR. Baseline characteristics were comparable after matching. LRLR was associated with a shorter duration of operation (median 200 (i.q.r. 123-273) versus 256 (199-320) min; P < 0·001), less intraoperative blood loss (200 (50-450) versus 300 (100-600) ml; P = 0·077) and a shorter postoperative hospital stay (5 (3-8) versus 6 (5-8) days; P = 0·028). Postoperative morbidity and mortality rates were similar after LRLR and ORLR.
CONCLUSION
LRLR for CRLM is feasible in selected patients and may offer advantages over an open approach.

Identifiants

pubmed: 30706451
doi: 10.1002/bjs.11096
doi:

Types de publication

Comparative Study Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

783-789

Informations de copyright

© 2019 BJS Society Ltd Published by John Wiley & Sons Ltd.

Auteurs

M J van der Poel (MJ)

Department of Surgery, University Hospital Southampton NHS Foundation Trust, Southampton, UK.
Department of Surgery, Cancer Centre Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.

L Barkhatov (L)

Interventional Centre and Department of Hepatopancreatobiliary Surgery, Oslo University Hospital - Rikshospitalet, Oslo, Norway.

D Fuks (D)

Department of Digestive Disease, Institut Mutualiste Montsouris, Université Paris Descartes, Paris, France.

G Berardi (G)

Department of General and Hepatobiliary Surgery, Ghent University Hospital, Ghent, Belgium.

F Cipriani (F)

Hepatobiliary Surgery Division, IRCCS San Raffaele Hospital, Milan, Italy.

A Aljaiuossi (A)

Department of Surgery, University Hospital Southampton NHS Foundation Trust, Southampton, UK.

P Lainas (P)

Department of Surgery, Antoine Béclère Hospital, Paris, France.

I Dagher (I)

Department of Surgery, Antoine Béclère Hospital, Paris, France.

M D'Hondt (M)

Department of Digestive and Hepatobiliary/Pancreatic Surgery, Groeninge Hospital, Kortrijk, Belgium.

F Rotellar (F)

Department of General and Abdominal Surgery, Clinica Universidad de Navarra, Pamplona, Spain.

M G Besselink (MG)

Department of Surgery, Cancer Centre Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.

L Aldrighetti (L)

Hepatobiliary Surgery Division, IRCCS San Raffaele Hospital, Milan, Italy.

R I Troisi (RI)

Department of General and Hepatobiliary Surgery, Ghent University Hospital, Ghent, Belgium.

B Gayet (B)

Department of Digestive Disease, Institut Mutualiste Montsouris, Université Paris Descartes, Paris, France.

B Edwin (B)

Interventional Centre and Department of Hepatopancreatobiliary Surgery, Oslo University Hospital - Rikshospitalet, Oslo, Norway.

M Abu Hilal (M)

Department of Surgery, University Hospital Southampton NHS Foundation Trust, Southampton, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH